ETF News: Vangaurd Group’s REIT ETF Is Long Term Value Opportunity

ETF News: Why Vanguard Group’s REIT ETF Is Both A Short Term Swing And Long Term Value Opportunity
  • Summary of the ETF’s portfolio, assets, and allocation.
  • Explanation of the resistance after reaching pre-crisis price levels.
  • The S&P/Case-Shiller US National Home Price Index looks well aligned for growth in upcoming months.
  • Algorithmic analysis explaining the short term opportunity of this long term value investment.
Portfolio characteristics and structure

ETF News The 14 days and 1 month forecast identifies Vanguard REIT ETF with a strong likelihood of appreciating in these time horizons, identified by the signals 18.9 and 17.01 respectively. The combination of a short term opportunity with solid fundamentals and track record present this ETF as a truly attractive opportunity. Investors interested in real estate should strongly consider it as a part of their portfolio.

Gilead Sciences Stock News: An Algorithmic Perspective


  • Gilead Sciences, Inc., an American biotechnologygilead sciences stock news company with international operations and twenty-plus innovative products, centers on discovering, developing, and commercializing treatments for a range of conditions (e.g., hep C, HIV).
  • After a year of increased revenue and product sales, Gilead is well off; its assorted innovative, novel products, abundance of research activity, and international accessibility initiatives all strengthen the company.
  • Harvoni and Sovaldi are particularly responsible for these positive trends; Gilead predicts that they will continue facilitating sales growth.
  • The I Know First algorithm contradicts analysts and the fundamental outlook. Gilead poses a risk in the next month of a downswing; however, it holds strong long-term value investing.

Company Profile: Gilead Sciences, Inc.

Gilead Sciences (NASDAQ:GILD) is an American biotechnology company that is involved in drug discovery, development, and commercialization, centering on treatments for HIV, hepatitis B, influenza, an assortment of pulmonary, liver, and cardiovascular diseases, cancer, and - most recently - hepatitis C. Initially founded in California, the company now has operations across North America, Europe, and Australia, and boasts an impressively diverse product line (to be specific, the company produces approximately twenty therapies, some of them wildly successful (e.g., Sovaldi), and each with a slightly different focus).

Read The Full Article Here

Blackberry Stock Predictions For 2015

In our previous article, after receiving strong bearish blackberry stock predictionssignals for Blackberry (BBRY) we recommended to short sell the stock in the one-month horizon. This eventually materialized to a decline of over 10% and a nice short profit. The problem was that Blackberry had no estimable value, rather very speculative guesses by the market and investors. Recent rumors that Samsung (005930.KS) might be pursuing Blackberry patents might add enough implied value to make the stock an interesting investment.

Why Blackberry Is Worth Looking At

Every piece of information we receive has a meaning, sometimes more valuable and sometimes less. When the news broke out that Samsung was bidding on Blackberry it was a much more significant event than most people realized. In fact, the information was the first estimate as to what the company’s worth might actually be in the future. Below are some obvious and simple conclusions, assuming the bid was real - which has recently been confirmed by various sources.

IBM Is Undervalued And Provides Vast Upside In 2015: Algorithmic Analysis


  • IBM has shifted to new software driven businesses, focusing on higher margins and value.
  • The company’s fourth quarter earnings are notalgorithmic analysis as bad as they appear at first glance, and are part of the transition.
  • Strong partnerships with recognizable companies provide credibility and opportunities to IBM’s new business units.
  • A DCF valuation and algorithmic analysis show that IBM is greatly undervalued in the long term.
The current technological landscape has changed rapidly in the last few years, severely affecting legacy IT companies such as International Business Machines Corp. (NYSE:IBM). The emergence of AS-a-Service represents a fundamentally disruptive series of impacts to the traditional IT and business services industry. Adapting to this new economic environment means IBM must transition the company, shifting the focus away from consulting, design, and implementation of one-off IT systems. Big Blue has recognized the changing environment and has made steps to do so.

Under Ginni Rometty, who became CEO in 2012, IBM has rapidly shifted its business portfolio, investing in what she calls strategic imperatives. These new businesses the company has earmarked for growth are Watson, cloud, security, services, systems, commerce, and analytics. At the same time, it has sold off businesses that generated several billion dollars in revenue but lost money or barely broke even in its attempt to focus on areas where it sees the most value.

Read The Full Article On Seeking Alpha